Cargando…
Dapsone induced hemolysis in a patient with Hansen’s disease and G6PD deficiency: A preventable peril
Although under‐reported, hemolytic anemia is common with dapsone‐containing regimen in leprosy. It is prudent to screen for underlying G6PD deficiency in boys before administering dapsone to prevent potentially life‐threatening episode of intravascular hemolysis in children with leprosy.
Autores principales: | Ghorui, Arnab Kumar, Patra, Pratap Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043721/ https://www.ncbi.nlm.nih.gov/pubmed/35498357 http://dx.doi.org/10.1002/ccr3.5700 |
Ejemplares similares
-
Dapsone Induced Methemoglobinemia and Hemolysis in a G6PD Deficient Girl, Possibly Aggravated by Aggressive Methylene Blue Therapy
por: Ghatak, Tanmoy, et al.
Publicado: (2013) -
Fulminant hemolysis in glucose‐6‐phosphate dehydrogenase deficiency
por: Moiz, Bushra, et al.
Publicado: (2017) -
Dapsone-induced agranulocytosis in patients with Hansen's
disease
por: Fernandes, Tania Rita Moreno de Oliveira, et al.
Publicado: (2017) -
A Rare Case of Hansen’s Disease Complicated by G6PD Deficiency
por: Yerke Hansen, Payton, et al.
Publicado: (2023) -
Interesting case of G6PD deficiency anemia with severe hemolysis
por: Chhabra, Anupam, et al.
Publicado: (2013)